Search research articles
Contact Us
Filters
Showing results (21-30 of 24) with videos related to
Page
of 3
Sort By:
You have reached the last page of results.
This site can display upto 24 results.
JAMA
|
November 23, 2006
Botulism in 4 adults following cosmetic injections with an unlicensed, highly concentrated botulinum preparation
Daniel S Chertow, Esther T Tan, Susan E Maslanka, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
May 28, 2015
Anti-EFNA4 Calicheamicin Conjugates Effectively Target Triple-Negative Breast and Ovarian Tumor-Initiating Cells to Result in Sustained Tumor Regressions
Marc Damelin, Alexander Bankovich, Albert Park, et al.
Marine Drugs
|
March 25, 2017
An Updated Review of Ciguatera Fish Poisoning: Clinical, Epidemiological, Environmental, and Public Health Management
Melissa A Friedman, Mercedes Fernandez, Lorraine C Backer, et al.
Science Translational Medicine
|
January 13, 2017
A PTK7-targeted antibody-drug conjugate reduces tumor-initiating cells and induces sustained tumor regressions
Marc Damelin, Alexander Bankovich, Jeffrey Bernstein, et al.
Page
of 3
Search research articles
Search
Showing results (21-30 of 24) with videos related to
Sort By:
Page
of 3
You have reached the last page of results.
This site can display upto 24 results.
JAMA
|
November 23, 2006
Botulism in 4 adults following cosmetic injections with an unlicensed, highly concentrated botulinum preparation
Daniel S Chertow, Esther T Tan, Susan E Maslanka, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
May 28, 2015
Anti-EFNA4 Calicheamicin Conjugates Effectively Target Triple-Negative Breast and Ovarian Tumor-Initiating Cells to Result in Sustained Tumor Regressions
Marc Damelin, Alexander Bankovich, Albert Park, et al.
Marine Drugs
|
March 25, 2017
An Updated Review of Ciguatera Fish Poisoning: Clinical, Epidemiological, Environmental, and Public Health Management
Melissa A Friedman, Mercedes Fernandez, Lorraine C Backer, et al.
Science Translational Medicine
|
January 13, 2017
A PTK7-targeted antibody-drug conjugate reduces tumor-initiating cells and induces sustained tumor regressions
Marc Damelin, Alexander Bankovich, Jeffrey Bernstein, et al.
Page
of 3